Attached files

file filename
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42015ex312.htm
EX-10.5 - MANUFACTURING SERVICES AGREEMENT - Jazz Pharmaceuticals plcjazzq42015ex105.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcjazzq42015ex321.htm
EX-10.23 - EXECUTIVE CHANGE IN CONTROL PLAN - Jazz Pharmaceuticals plcjazzq42015ex1023.htm
EX-10.22B - CASH BONUS PLAN U.S. - Jazz Pharmaceuticals plcjazzq42015ex1022b.htm
EX-10.22D - CASH BONUS PLAN OTHER - Jazz Pharmaceuticals plcjazzq42015ex1022d.htm
10-K - ANNUAL REPORT ON FORM 10-K - Jazz Pharmaceuticals plcjazz1231201510k.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42015ex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Jazz Pharmaceuticals plcjazzq42015ex231.htm


EXHIBIT 21.1
Subsidiaries of the Registrant



Name of Subsidiary
State or Jurisdiction of Incorporation or Organization
 
 
 
 
Jazz Pharmaceuticals Ireland Limited
Ireland
Jazz Financing I Limited
Ireland
Jazz Capital Limited
Ireland
Jazz Pharmaceuticals, Inc.
Delaware
Jazz Pharmaceuticals Holdings Inc.
Delaware
Jazz Pharmaceuticals Europe Holdings Limited
Gibraltar
EUSA Pharma SAS
France
EUSA Pharma Holdings SAS
France
Jazz Pharmaceuticals Lux S.à.r.l.
Luxembourg
Jazz Pharmaceuticals Italy S.r.l.
Italy
Gentium S.r.l.
Italy